{"id":"anazolene","rwe":[{"pmid":"28946435","year":"2018","title":"Heterogeneous sonocatalytic degradation of anazolene sodium by synthesized dysprosium doped CdSe nanostructures.","finding":"","journal":"Ultrasonics sonochemistry","studyType":"Clinical Study"}],"tags":[{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"phase_2","safety":{"commonSideEffects":[]},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":["anazolene","anazolene sodium","sodium anoxynaphthonate"],"offLabel":[],"synonyms":["anazolene","anazolene sodium","sodium anoxynaphthonate"],"timeline":[],"ecosystem":[],"mechanism":{"modality":"Small Molecule","explanation":"Imagine ANAZOLENE as a key that fits into a specific lock in the body. When it binds to this lock, it triggers a series of events that help to treat a particular condition. This process is like a series of dominoes falling, where ANAZOLENE's presence sets off a chain reaction that ultimately leads to the desired outcome.","oneSentence":"ANAZOLENE works by interacting with specific biological pathways to produce its therapeutic effects.","technicalDetail":"ANAZOLENE's mechanism of action is likely to involve the modulation of a specific protein or receptor, which in turn affects downstream signaling pathways and ultimately leads to its therapeutic effects."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/211","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=ANAZOLENE","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T08:47:52.771737","biosimilars":[],"competitors":[],"genericName":"anazolene","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"9JUJ56C686","CHEBI":"CHEBI:135858","INN_ID":"1070","UMLSCUI":"C2698112","ChEMBL_ID":"CHEMBL1555467","KEGG_DRUG":"D02936","PUBCHEM_CID":"19732","SECONDARY_CAS_RN":"7488-76-8"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":1,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[{"date":"2018 Jan","pmid":"28946435","title":"Heterogeneous sonocatalytic degradation of anazolene sodium by synthesized dysprosium doped CdSe nanostructures.","journal":"Ultrasonics sonochemistry"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","brandName":"ANAZOLENE","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Anazolene is a small molecule. It is also known by various synonyms, including Anazolene Sodium, Sodium Anazolene, and NSC-47734.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}